Time Courses of Matrix Metalloproteinases and Tissue Inhibitors of Matrix Metalloproteinases in Systemic Inflammation and Revascularisation by Nagy Bálint
 
 
 
Time courses of matrix metalloproteinases and tissue 
inhibitors of matrix metalloproteinases in systemic 
inflammation and revascularisation 
 
Ph.D. thesis 
 
Author: Bálint Nagy, M.D. 
 
 
Leader of Doctoral School: Gábor L. Kovács, M.D., Ph.D., D.Sc. 
Leader of Doctoral Program: Gábor Jancsó, M.D., Ph.D. 
 
Supervisors: 
 
Diána Mühl, M.D., Ph.D.            János Lantos, Ph.D. 
 
 
 
Medical School  
University of Pécs 
2017 
 
 
 
 
 
Contents 
 
 
1. Introduction ....................................................................................................................... 1 
2. Aims .................................................................................................................................... 2 
3. Methods .............................................................................................................................. 3 
3.1 MMP-TIMP system in burns related SIRS, patients, inclusion and exlusion 
criteria ......................................................................................................................... 3 
3.2    MMP-TIMP system in severe sepsis, patients, inclusion and exlusion criteria ... 4 
3.3 MMP-TIMP system in the perioperative periode of carotid endarterectomy 
(CEA), patients, inclusion and exlusion criteria ..................................................... 4 
3.4 Control groups ........................................................................................................... 5 
3.5 Blood sampling ........................................................................................................... 5 
3.6 MMP-TIMP assays .................................................................................................... 6 
3.7 Statistical analysis ...................................................................................................... 6 
4. Results ................................................................................................................................ 7 
4.1 Time course of the MMP-9-TIMP-1 system in burns related SIRS ..................... 7 
4.2 Time course of the MMP-TIMP system in severe sepsis........................................ 9 
4.3 Time course of the MMP-TIMP system in carotid endarterectomy ................... 11 
5. Discussion ......................................................................................................................... 13 
6. Novel findings .................................................................................................................. 14 
7. Publications ..................................................................................................................... 16 
 
 
  
1 
 
1. Introduction 
 
Martrix metalloproteinases (MMPs) are structurally related, but genetically distinct zinc- 
and calcium-dependent endopeptidase enzymes. The history of MMPs started more than 50 
years ago when Gros and Lapiere observed enzymatic activity during tadpole tail 
metamorphosis by placing a tadpole tail in a collagen matrix plate. The initially discovered 
enzyme was named interstitial collagenase (MMP-1) after its activity. Later MMP-1 was 
purified from human skin and was recognised to be synthesized as a zymogen. More than 25 
members have been identified of these widespread enzyme family since 1962. The basic roles 
of MMPs are extracellular matrix degradation and remodelling. Besides these original 
functions, MMPs play an important role in tissue remodelling associated with various 
physiological and pathological processes such as morphogenesis, angiogenesis, tissue repair, 
cirrhosis, arthritis and metastasis. The first naturally occurring (endogen) inhibitor of matrix 
metalloproteinases was isolated from sera in 1970 and named as TIMP-1. Since 1970 four 
TIMPs have been described (TIMP-1, TIMP-2, TIMP-3, and TIMP-4). TIMPs are small and 
stable proteins with the ability to inhibit MMPs activity by forming non-covalent bond with 
MMPs in stoichiometric ratio (1:1). This type of inhibition is non-specific, therefore an inhibitor 
is able to act on many different enzymes. Besides regulating MMPs, TIMPs have several 
already proven functions for instance, in cellular differentiation and in apoptosis (anti-apoptotic 
effect).  
The general importance of sepsis and systemic inflammatory response syndrome (SIRS) in 
medicine is not a question anymore. Sepsis related annual mortality in the developed countries 
has reached the level of cardiovascular diseases related mortalities. Due to clinical advances the 
mortality has decreased in tendency, but unfortunately the rising incidence of sepsis keeps the 
related annual mortality rate at the aforementioned high level. Sepsis associated health care 
expenditures are high as well. Therefore, researchers faced toward exploring pathophysiology 
of sepsis and SIRS to facilitate better therapies and outcomes. Ischemic-reperfusion injuries 
(IRI) are vastly related to surgical procedures. SIRS and sepsis might be the complications of 
IRI. However in the majority of cases, IRI associates to subclinical complications like 
postoperative cognitive dysfunction in carotid surgery. The importance of the MMP-TIMP 
system in SIRS, sepsis and in IRI is presumed, therefore we aimed to explore the time courses 
to facilitate better understanding and future therapies.     
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2. Aims 
 
Aims of the investigation regarding burns related SIRS and its time course: 
1. Identification of any significant changes of MMP-9 and TIMP-1 plasma concentrations. 
2. Evaluation of plasma MMP-9-TIMP-1 activity dynamics (MMP-9/TIMP-1 ratio). 
3. Exploring the predictive value of MMP-9, TIMP-1 and MMP-9/TIMP-1 ratio in sepsis 
development. 
 
Aims of the investigation regarding severe sepsis and its treatment: 
4. Identification of any significant changes of MMP-2, MMP-9, TIMP-1 and TIMP-2 plasma 
concentrations. 
5. Exploring relationships between severe sepsis-related MMP-9 and TIMP-1 dynamics and 
SIRS related ones. 
6. Evaluation of relationship between TIMP-1 plasma levels and mortality. 
7. Description of MMP-TIMP activity changes during the course of treatment (MMP-2/TIMP-
1; MMP-2/TIMP-2; MMP-9/TIMP-1; MMP-9/TIMP-2 ratios). 
8. Identification of relationships between MMP-TIMP activity in severe sepsis and the course 
of the disease. 
9. Exploring relationships between severe sepsis-related MMP-9/TIMP-1 ratio dynamics and 
SIRS related ones. 
 
Aims of the investigation regarding the perioperative period of carotid endarterectomy: 
10. Identification of any significant changes of MMP-9 and TIMP-1 plasma concentrations. 
11. Evaluation of plasma MMP-9-TIMP-1 activity dynamics (MMP-9/TIMP-1 ratio). 
12. Exploring the predictive value of MMP-9, TIMP-1 and MMP-9/TIMP-1 ratio in 
perioperative clinical complications. 
13. Evaluation of the effects of pharmacological secunder prevention on MMP-9 and TIMP-1 
plasma concentrations and on MMP-9-TIMP-1 system activity. 
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3. Methods 
 
 All the study protocols fulfilled the ethical guidelines of the Declaration of Helsinki 
(2003 and later 2008), and permission was obtained from the Institutional Scientific and Human 
Research Ethics Committee of the University of Pécs (4282.316-2216/KK15/2011, 2406/2005, 
4330/2011, 4330/2013) prior to investigations. 
 
3.1 MMP-TIMP system in burn-related SIRS, patients, inclusion and exlusion criteria 
This retrospective study was performed using the remaining blood samples of burn 
patients (n=31) who participated in our previous studies. Only the blood samples of patients 
taken between March 2005 and May 2010 were investigated. The patients were treated 
uniformly, and they received no study medications. Inclusion and exclusion criteria were 
similar as in the original studies: 
 
Inclusion criteria: 
 burn injury affecting more than 15% of the body surface are (BSA)  
 admission to our ward within 6 hours after injury  
 patients met SIRS criteria.  
 
Exclusion criteria:  
 patients younger than 18 years old  
 electrical injury  
 bacterial infection on admission  
 extreme burn severity (> 80%)  
 previously documented chronic left heart or renal insufficiency  
 known malignant disease  
 documented previous medication affecting the inflammatory response of the body to burns 
(e.g. chronic use of corticosteroid). 
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3.2 MMP-TIMP system in severe sepsis, patients, inclusion and exclusion criteria  
 Patients (n = 38) treated for severe sepsis were included in our study. The diagnosis of 
severe sepsis was assessed by the New Simplified Acute Physiology Score (SAPS II), the 
Sequential Organ Failure Assessment (SOFA) score, and the Multiple Organ Dysfunction Score 
(MODS), also the American College of Chest Physicians/Society of Critical Care Medicine 
consensus was considered: 
 
Inclusion criteria: 
 2 or more organ dysfunctions 
 sepsis-induced hypotension and serum procalcitonin level > 5 ng/ml  
 sepsis-induced tissue hypoperfusion 
Exclusion criteria:  
 patients younger than 18 years old   
 known malignant disease  
 documented previous medication affecting the inflammatory response of the body to sepsis 
(e.g., chronic use of corticosteroid) 
 
 
3.3 MMP-TIMP system in the perioperative period of carotid endarterectomy (CEA), 
patients, inclusion and exclusion criteria  
 
 All patients scheduled for elective CEA at the Clinical Center of the University of Pécs, 
Hungary in 2012 were considered. They were included consecutively between January to 
December 2012. In 2012, a total of 66 patients were scheduled for elective CEA. Twelve 
patients were excluded as five met the exclusion criteria and seven refused to participate. 
Overall, 54 patients were included in the study. 
Exclusion criteria:  
 patients younger than 18 years old   
 known malignant disease  
 previous debilitating stroke 
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 psychiatric disorders 
 documented previous medication affecting the inflammatory response of the body to sepsis 
(e.g., chronic use of corticosteroid) 
 
3.4 Control groups 
- In „MMP-TIMP in SIRS and severe sepsis” studies 10 and 17 healthy, age- and sex-
matched individuals served as controls respectively.  
- In „MMP-TIMP in CEA” study 20 atherosclerotic patients scheduled for outpatient 
ophthalmological examinations were invited as controls. No significant difference was 
observed regarding age, gender, medications, and coexisting diseases compared to the 
operated group, but controls were scanned with ultrasound to be free from significant 
carotid diseases. Controls were also free from symptoms and positive medical history 
regarding cerebral atherosclerosis and carotid diseases.  
3.5 Blood sampling 
Blood sampling was carried out once from every volunteer of the control groups. By SIRS, 
septic, and CEA patients blood samples were collected via radial artery cannula according to 
the following protocols: 
- SIRS patients: 
Blood samples were taken right after patients met SIRS criteria (day 1) and on the 5 
consecutive days (days 2-6) at 7 AM before operations or painful dressing changes. 
 
- Severe septic patients: 
Blood samples were taken on admission (day 1) and on the 4 consecutive days (days 2-5) 
at 7 AM before painful interventions. 
 
- CEA patients: 
Samples were withdrawn at four time points (T1-4), T1: right after the insertion of the 
arterial line at the operating theater, T2: 60 min after the cross-clamp release, T3: first 
postoperative morning, T4: third postoperative morning.  
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3.6 MMP-TIMP assays 
 
 Plasma was isolated from heparin anticoagulated blood samples by low speed 
centrifugation at 4°C, and stored at −80°C until analyzed in a single batch. MMP-2, MMP-9, 
TIMP-1 and TIMP-2 were determined by the quantitative sandwich enzyme-linked 
immunosorbent assay (ELISA) techniques according to the manufacturer's instructions (R&D 
Systems, Inc, Minneapolis, MN). In comparison with standard MMP-2, MMP-9 and TIMP-1, 
TIMP-2 curves, the concentrations of MMP-2, MMP-9, TIMP-1 and TIMP-2 in plasma were 
determined spectrophotometrically (Multiskan Ascent microplate photometer, Type: 354; 
Thermo Electron Corporation, Waltham, MA) by reading the absorbance at 450 nm and were 
expressed as entire amounts in the plasma (nanograms per milliliter). The assays were executed 
at the Department of Surgical Research and Techniques, University of Pécs, Hungary. 
 
3.7 Statistical analysis         
 
The analyses were conducted by Statistical Package for the Social Sciences Statistics 
software, version 20. and 21. (SPSS, IBM Corporation, Armonk, NY, USA). Kolmogorov-
Smirnov test was used to assess the distribution. In case of normal distribution, Student's t test 
was applied, otherwise, Wilcoxon signed-rank test or Mann-Whitney U test was used for the 
analysis of nonparametric data. Patients and controls were compared with Mann-Whitney U 
test, while intergroup analysis was conducted by Wilcoxon signed-rank test. Jonckheere-
Terpstra test was used to detect significant trends. Correlations were analyzed with Spearman 
test. Data were expressed as minimum, maximum, median, and interquartile range (standard 
25th-75th percentile). Using univariate and multivariate linear regression models, the 
influencing factors were evaluated on dependent variables. Values of P<0.05 were considered 
significant.  
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4. Results 
 
4.1 Time course of the MMP-9-TIMP-1 system in burns related SIRS  
 
 By burns in general, the most frequent complications are sepsis and respiratory, cardiac, 
and renal failure. However, the leading causes of death during the trial period were cardiac 
(67%) and respiratory failure (33%), and we experienced no septic complications. Therefore, 
our study population could represent the postinjury SIRS period well. Six-day study interval 
has been chosen because we presumed that a 6-day period would open a wide time window that 
could be enough for detecting both the ascending and descending inflammatory responses. No 
correlations were detected between enzyme levels and common severity scores (Multiple Organ 
Dysfunction Score, Sequential Organ Failure Assessment, and Simplified Acute Physiology 
Score II) on admission.  
 
Results of MMP-9 measurements  
 MMP-9 levels on admission and day 2 were significantly higher in burned patients than 
in healthy volunteers, whereas MMP-9 levels on days 4 to 6 were significantly lower in burned 
patients. MMP-9 showed a decreasing tendency during the whole study period (P <0.001), its 
levels were significantly lower on days 2 to 6 compared to admission levels (Fig. 1a).  
 
Results of TIMP-1 measurements  
 There was no significant difference between healthy controls and burned patients 
regarding TIMP-1 on admission, but it was significantly higher in burned patients on days 2 to 
6. Comparing admission values with those of the following days TIMP-1 showed a significant 
elevation from the second day until the end of the study (P <0.001) (Fig. 1b).  
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Results of MMP-9/TIMP-1 measurements  
 The time course of MMP-9/TIMP-1 followed the dynamics of MMP-9. MMP-9/TIMP-
1 ratios were significantly higher in burned patients compared with healthy volunteers on 
admission and significantly lower on days 3 to 6. MMP-9/TIMP-1 ratio decreased continuously 
(P <0.001) (Fig. 1c).  
 
 
Fig. 1. MMP-9, TIMP-1 and MMP-9/TIMP-1 plasma levels in SIRS 
Plasma levels of MMP-9 (a), TIMP-1 (b), and MMP-9/TIMP-1 ratio (c) in the control and in the patient groups. 
Data are expressed as minimum, maximum, median, and IQR (standard 25th-75th percentile and 5th and 95th 
confidence interval). Shaded boxes represent SIRS patients; white boxes show healthy control results. The “#” 
symbols show significant differences (P <0.05) in patients compared with controls (#P <0.05, ##P <0.01, ###P 
<0.001). Asterisks indicate statistical differences within the SIRS group compared with day 1 
(⁎P <0.05, ⁎⁎P <0.01, ⁎⁎⁎P <0.001).  
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4.2 Time course of the MMP-TIMP system in severe sepsis 
 
 
Fig. 2.  MMP-2, MMP-9, TIMP-1 and TIMP-2 plasma levels in severe sepsis 
Plasma levels of MMP-2 (A), MMP-9 (B), TIMP-1 (C), and TIMP-2 (D) on admission (day 1) and on the 4 
consecutive days thereafter (days 2-5). Data are expressed as minimum, maximum, median, and interquartile 
range. Shaded boxes represent severe septic patients, white boxes show healthy control results. Asterisks indicate 
statistical differences (P <0.05) inside the septic group compared to day 1. The “#” symbols show significant 
difference (P <0.05) in severe septic patients compared to controls.  
 
Results of MMP and TIMP measurements 
 MMP-2 levels were elevated although not significantly by days 2 and 3, but by day 4 
they decreased to the control levels (Fig. 2A). The plasma MMP-9 levels were significantly 
higher (P <0.005) on admission and reduced significantly by day 3 (P <0.009). At the 
consecutive days, the MMP-9 remained at this nonsignificantly elevated level (Fig. 2B). The 
plasma level of TIMP-1 (Fig. 2C) was significantly elevated (P <0.002-0.004) during the whole 
study period compared to controls. It decreased significantly from day 3 (P <0.006). Except for 
day 2, the plasma level of TIMP-2 was significantly (P <0.05-0.009) lower in septic patients 
(Fig. 2D).  
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Fig. 3. MMP/TIMP plasma levels in severe sepsis 
MMP-2/TIMP-1 (A), MMP-2/TIMP-2 (B), MMP-9/TIMP-1 (C) and MMP-9/TIMP-2 (D) ratios in plasma 
samples on admission (day 1) and on the 4 consecutive days thereafter (days 2–5). Data are expressed as 
minimum, maximum, median, and interquartile range. Shaded boxes represent severe septic patients, white 
boxes show healthy control results. Asterisks indicate statistical differences (P <0.05) inside the septic group 
compared to day 1. The “#” symbols show significant difference (P <0.05) in severe septic patients compared to 
controls. 
 
Results of MMP/TIMP measurements 
 The MMP-2/TIMP-1 ratio (Fig. 3A) was significantly decreased during the whole 
observation period compared to controls (P <0.004-0.002) and elevated significantly from day 
3 (P <0.001). MMP-2/TIMP-2 ratio was significantly elevated during all 5 days in septic 
patients (P <0.03-0.006) (Fig. 3B). MMP-9/TIMP-1 ratio was significantly lower in septic 
patients compared to healthy controls on the first 3 days (P <0.05-0.008) (Fig. 3C). MMP-
9/TIMP-2 ratio was significantly (P <0.006) elevated on admission in septic patients and 
remained above the normal values during the 5-day-long investigation (Fig. 3D).  
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4.3 Time course of the MMP-TIMP system in carotid endarterectomy 
 
 Laterality of the surgery, contralateral stenosis, gender, pre-existing diseases such as 
diabetes and hypertension, and nicotine abuse did not significantly influence plasma levels of 
MMP-9 or TIMP-1 in our study population. The potential effects of aspirin, adenosine 
diphosphate (ADP) receptor antagonists, and lipid lowering agents were evaluated on MMP-9 
and TIMP-1 levels. Patients on ADP receptor antagonists (clopidogrel or ticlopidine) had lower 
(P <0.05) circulating TIMP-1 levels at baseline (T1). Acetyl salicylic acid had no influence on 
the measured variables at any time point. Intraoperative bleeding and cross-clamp time (CCT) 
were selected for final linear multivariate analysis regarding MMP-9 levels at T3 and it was 
noted that 15 per cent of total variability could be explained by the model (P <0.05). Patients 
requiring temporary shunt insertion had lower (Spearman rho=0.35, P <0.05) TIMP-1 values at 
baseline (T1). Using stepwise logistic multivariate regression, diabetes, preoperative S100B 
and TIMP-1 levels were selected for a final model to predict shunting. Using a model including 
these variables, we were able to predict 100 per cent of shunting (Nagelkerke R2=1; Hosmer 
and Lemeshow test P =1.00). 
    
 
Results of MMP, TIMP and MMP/TIMP measurements 
The results regarding MMP-9, TIMP-1 and MMP- 9/TIMP-1 plasma levels are 
summarized in Fig. 4.  
Except at T1 the plasma level of TIMP-1 was significantly lower (P <0.05) compared to 
controls during the whole study period. Comparing to the preoperative values (T1), after 
reperfusion (T2) we experienced decreased (P <0.05) TIMP-1 levels and TIMP-1 remained at 
this significantly lower (P <0.05) level at the first postoperative day (T3), but returned almost 
to the baseline by T4 (Fig. 4B). Plasma MMP-9 levels were increased (P <0.05) compared to 
controls at T1 and remained significantly elevated (P <0.05) during the whole investigation. 
Significant elevation (P <0.05) of MMP-9 levels was noted at T3 compared to T1 then values 
decreased to approximate T1 levels by T4 (Fig. 4A). 
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Fig. 4. MMP-9, TIMP-1 and MMP-9/TIMP-1 plasma levels in carotid endarterectomy (CEA) 
Plasma levels of MMP-9 (A), TIMP-1 (B), and MMP-9/TIMP-1 ratio (C) in the control and in the patient 
groups. Data are expressed as minimum, maximum, median, and IQR (standard 25th-75th percentile and 5th and 
95th confidence interval). Shaded boxes represent CEA patients, white boxes show control results. The “#” 
symbols show significant differences (P <0.05) in patients compared with controls. Asterisks indicate statistical 
differences (P <0.05) within the CEA group compared with T1. T1: preoperative values; T2: 60 min after cross-clamp 
release; T3: postoperative day 1; T4: postoperative day 3. 
 
 
  MMP-9/TIMP-1 ratios were markedly increased (P <0.05) at all time points compared 
to controls. By reperfusion (T2) the ratio of MMP-9/TIMP-1 elevated significantly (P <0.05) 
and by T3 further elevation (P<0.05) was observed compared to T1. By T4 the MMP-9/TIMP-1 
ratio decreased almost to the T1 level (Fig. 4C). 
 Diabetes mellitus (DM) was associated with prolonged CCT (P <0.05). There was a 
positive correlation between CCT and age of the patients (Spearman rho=0.35, P <0.05). No 
significant correlation was observed between CCT and the measured variables (MMP-9, TIMP-
1, MMP-9/TIMP-1, and S100B) at any time point. We selected diabetes, age of patients and 
nicotine abuse as independent variables for multivariate linear regression analysis, which 
showed that 19 per cent of total variability in CCT was explained by the selected variables (P 
<0.05). 
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5. Discussion 
 
 The MMP-TIMP system and the ECM are considered to be dynamic structures. 
Dynamic interactions of numerous different pathophysiological processes (release of 
inflammatory mediators, MMP activation, TIMP suppression/activation) are triggered by 
noxious stimulation (injury, infection, ischemia) of the human body. Pathological conditions 
(sepsis, POCD, stroke) or healing process will be initiated based on the results of the 
aforementioned complex interactions. These processes are linked in time as we managed to 
prove. The processes and markers of SIRS, severe sepsis and CEA should not be evaluated in 
subjectively selected time points, but time courses should be taken into consideration prior 
investigations to prevent questionable conclusions. Subjectively selected time points have been 
frequently used recently regarding MMP-TMP system in the literature, thus scientific 
information have gained might be questionable. Our investigations regarding the time courses 
of MMP-TIMP system have also used subjectively selected time points, but based on its 
frequency we gained valuable tendencies to help future investigations in the fields of SIRS, 
severe sepsis and CEA.  
 The predictive role of MMP’s and TIMP’s have raised recently in the literature 
regarding many different diseases and endpoints. MMP-9, TIMP-1, and MMP-9/TIMP-1 have 
been implicated regarding sepsis outcome, while in CEA related POCD MMP-9 suspected to 
be important. It is important to be highlighted that statistical significance between a biomarker 
and a disease/outcome should not be considered as strict causal relationship. The MMP-TIMP 
system has close and complicated interactions with many important systems (interleukins, 
cytokins), therefore interventions even with specific inhibitors could cause unanticipated, 
potentially disastrous results.  
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6. Novel findings 
 
 We have managed to prove the followings regarding MMP-TIMP system in 
SIRS and severe sepsis: 
1. Dynamic changes could be observed in plasma MMP-9 and TIMP-1 concentrations, thus in 
plasma MMP-9-TIMP-1 activity by time course of SIRS and severe sepsis. We managed to 
describe the MMP-9-TIMP-1 patterns related to injury, SIRS, and sepsis. In concordance 
with the literature we believe, that the observed dynamics are related to the time courses of 
pro- and anti-inflammatory processes.  
2. MMP-9 plasma levels increase right after injury, while TIMP-1 remains unchanged. The 
relationship between the extent of injury and MMP-9 might be suspected, but the evidences 
in the literature are still contradictory in this regard.  
3. In SIRS the MMP-9 decrease and TIMP-1 increase in tendency, while in sepsis MMP-9 
levels are normal/near normal and TIMP-1 levels are markedly increased. The MMP-
9/TIMP-1 ratios have proven reduced in sepsis. 
4. In remission of sepsis the TIMP-1 and the MMP-9/TIMP-1 normalize in tendency, while 
MMP-9 levels are still in normal range. Persistently elevated TIMP-1 and decreased MMP-
9/TIMP-1 in this phase might be a marker of negative outcome according to the literature. 
5. With the help of two different studies we managed to prove relationship between the time 
courses of MMP-9-TIMP-1 plasma kinetics in different, but related pathophysiological 
processes (injury, SIRS, sepsis), which result is in concordance with previous findings.    
6. No changes could be observed in sepsis regarding MMP-2 plasma levels, thus its role in 
sepsis is unlikely.  
7. Based on the aforementioned conclusion the role and usefulness of MMP-2 based activity 
markers (MMP-2/TIMP-1, MMP-2/TIMP-2) in sepsis are markedly questionable. 
8. The plasma levels of TIMP-2 might be decreased in septic patients, however its importance 
is still unclear. 
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We have managed to prove the followings regarding MMP-TIMP system in 
CEA: 
1. TIMP-1 levels proved to be normal prior surgery, while decrease thereafter, which might 
be the sign of increased ECM turnover after CEA. 
2. MMP-9 levels are increased throughout the immediate perioperative period, which might 
be related to increased atherosclerotic plaque instability prior CEA, while to 
microembolization, hypoperfusion or reperfusion after CEA surgery.  
3. Throughout the immediate perioperative period we managed to observe altered MMP-9-
TIMP-1 activity (MMP-9/TIMP-1 ratios), which might be related to increased 
atherosclerotic plaque instability prior CEA, while to increased ECM turnover after CEA 
surgery based on the literature. 
4. In the immediate perioperative period we managed to observe dynamic changes in MMP-9 
and TIMP-1 plasma levels and in MMP-9/TIMP-1 ratios, which might be related to the time 
courses of related processes (pro- and anti-inflammatory cytokines, ECM turnover, BBB 
injury) due to microembolisation and/or IRI. 
5. Significantly lower TIMP-1 plasma levels were observed prior CEA by patients taking ADP 
receptor blocker drugs regularly, however the reasons behind this finding are largely 
unclear. 
6. Decreased TIMP-1 levels prior CEA might be predictive to intraoperative shunt 
requirement, which might be related to plaque instability through increased MMP-9/TIMP-
1 activity. However, we could not find correlation between MMP-9/TIMP-1 ratios and 
shunt requirement, thus further studies are warranted for clarification.  
 
 
 
 
16 
 
 
7. Publications 
 
Publications related to the Thesis 
 
Original publications: 
Mühl D*, Nagy B*, Woth G, Falusi B, Bogár L, Weber Gy, Lantos J: Dynamic changes of 
matrix metalloproteinases and their tissue inhibitors in severe sepsis. Journal of Critical 
Care. 2011; 26(6):550-555. 
* = equal contribution, IF: 2.134, IF based on decision of first authors: 1.067  
Nagy B*, Szélig L*, Rendeki Sz, Loibl Cs, Rézmán B, Lantos J, Bogár L, Csontos Cs: 
Dynamic changes of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 
after burn injury. Journal of Critical Care. 2015; 30(1):162-166. 
* = equal contribution, IF: 2.445, IF based on decision of first authors: 1.223 
Nagy B, Woth G, Mérei Á, Nagy L, Lantos J, Menyhei G, Bogár L, Mühl D: Perioperative 
time course of matrix metalloproteinase-9 (MMP-9), its tissue inhibitor TIMP-1 & S100B 
protein in carotid surgery. The Indian Journal of Medical Research. 2016;143(2):220-226. 
IF (2015): 1.446 
 
Sum of original publications related impact factors: 3.736 
 
Abstracts: 
Nagy B, Woth G, Mérei Á, Lantos J, Bogár L, Mühl D: Altered balance of matrix 
metalloproteinases and their natural inhibitors during severe sepsis. Infection. 2013;41S:7-
8. 
IF: 2.864 
17 
 
Nagy B, Woth G, Mérei Á, Nagy L, Lantos J, Menyhei G, Bogár L, Mühl D: Mátrix 
metalloproteinázok és endogén inhibítoraik vizsgálata carotis endartherectomián átesett 
betegeken. Érbetegségek. 2013;20(4):96-97. 
 
Nagy B, Woth G, Bogár L, Lantos J, Mühl D: Mátrix metalloproteinázok és szöveti 
inhibítoraik jelentősége szepszisben. Aneszteziológia és Intenzív Terápia. 2013;43(S1):12. 
 
Nagy B, Woth G, Mérei Á, Nagy L, Lantos J, Menyhei G, Bogár L, Mühl D: When should 
we measure matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 
regarding postoperative cognitive dysfunction after carotid surgery? European Surgical 
Research. 2014;52S:134. 
IF: 2.474 
Nagy B, Woth G, Mérei Á, Nagy L, Lantos J, Menyhei G, Bogár L, Mühl D: A mátrix 
metalloproteináz-9 (MMP-9) – endogén szöveti inhibítor-1 (TIMP-1) rendszer perioperatív 
vizsgálata carotis endartherectomián átesett betegeken. Aneszteziológia és Intenzív 
Terápia. 2014;44(S1):4. 
  
 Sum of abstracts related impact factors: 5.338 
 
Other publications 
 
Original publications: 
Woth G, Nagy B, Mérei Á, Ernyey B, Vincze R, Kaurics Z, Lantos J, Bogár L, Mühl D: 
The effect of Na-selenite treatment on the oxidative stress–antioxidants balance of multiple 
organ failure. Journal of Critical Care. 2014;29(5):883e7-e11. 
IF: 1.995 
18 
 
Mérei Á, Nagy B, Woth G, Zsidó N, Lantos J, Mühl D: Effects of therapeutic hypothermia 
and kinetics of serum protein S100B after cardiopulmonary resuscitation. Signa Vitae. 
2015;10(2):7. 
IF: 0.154 
 
Abstracts: 
Woth G, Nagy B, Ernyey B, Kaurics Z, Vincze R, Bogár L, Mühl D: Szelén 
szupplementáció hatása a súlyos szepszis során kialakuló oxidatív stresszre. 
Aneszteziológia és Intenzív Terápia. 2013;43(S1):19. 
 
Woth G, Nagy B, Mérei Á, Ernyey B, Kaurics Z, Vincze R, Lantos J, Bogár L, Mühl D: 
The effect of sodium selenite substitution on oxidative stress markers and antioxidants in 
severe sepsis. Infection. 2013;41S:57. 
IF: 2.864 
Mérei Á, Nagy B, Woth G, Zsidó N, Lantos J, Mühl D: Terápiás hypothermia effektusa és 
protein S100B kinetika reanimációt követően. Aneszteziológia és Intenzív Terápia. 
2014;44(S1):15. 
 
Woth G, Nagy B, Rideg O: Többszervi elégtelen betegek plazma szabad DNS szintje 
fokozott Gram-negatív bakteriális fertőzésekben. Aneszteziológia és Intenzív Terápia. 
2014;44(S1):14. 
 
Nagy B, Woth G, Mérei Á, Lantos J, Bogár L, Mühl D: Dynamics of matrix 
metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) after 
cardiopulmonary resuscitation. Resuscitation. 2015;96S:137. 
IF: 5.414 
Sum of impact factors in total: 19.501 
 
19 
 
 
 
  
20 
 
